Clinical Scorecard: Diabetes Self-Care Declines During Breast Cancer Treatment
At a Glance
| Category | Detail |
|---|---|
| Condition | Diabetes management challenges during adjuvant breast cancer treatment |
| Key Mechanisms | Treatment-related symptoms disrupt diabetes routines; prioritization of cancer care over diabetes; reduced monitoring and emotional distress |
| Target Population | Patients with concurrent diabetes undergoing breast cancer treatment |
| Care Setting | Oncology and diabetes care settings, including outpatient and virtual care |
Key Highlights
- Diabetes self-care including diet, physical activity, glucose monitoring, and medication adherence declines during breast cancer treatment.
- Glycated hemoglobin testing and glycemic control worsen post-cancer diagnosis, with many patients reporting glucose levels exceeding 200 mg/dL.
- Emotional distress and cancer-related post-traumatic stress significantly impair perceived diabetes control and increase diabetes-related emotional impact.
Guideline-Based Recommendations
Diagnosis
- Monitor glycated hemoglobin regularly during breast cancer treatment to assess glycemic control.
- Distinguish symptoms related to cancer treatment from diabetes complications to guide management.
Management
- Prioritize integrated care coordination between oncology and diabetes clinicians to ensure concurrent management.
- Consider personalized diabetes care models, such as monthly virtual visits, to reduce diabetes distress and improve treatment satisfaction.
- Address treatment-related symptoms (fatigue, nausea, appetite loss) that disrupt diabetes self-care routines.
Monitoring & Follow-up
- Increase frequency of glucose monitoring during cancer treatment to detect and manage hyperglycemia promptly.
- Implement regular assessment of emotional distress and fatigue to support diabetes self-management.
Risks
- Reduced diabetes self-care increases risk of poor health outcomes and progression of diabetes-related complications.
- Cancer-related fatigue and emotional distress exacerbate difficulties in maintaining glycemic control.
Patient & Prescribing Data
Patients with breast cancer and pre-existing diabetes undergoing adjuvant treatment
Adherence to diabetes medications declines during cancer treatment; personalized virtual care interventions may improve adherence and reduce distress.
Clinical Best Practices
- Ensure clear communication and role delineation between oncology and diabetes care providers.
- Incorporate routine emotional and symptom burden assessments into diabetes management during cancer treatment.
- Utilize telehealth or virtual care models to provide ongoing diabetes support during breast cancer therapy.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
